Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea

American Journal of Medicine

Volumn 117, Issue 2, 2004, Pages 118-121

  Barceló, Antonia ^a   Barbé, Ferrán ^b   Llompart, Elena ^a   Mayoralas, Lola R ^b   Ladaria, Antoni ^b   Bosch, Margalida ^b   Agustí, Alvar G N ^b,c  

^a Servei de Analisis Cliniques (AB   (Spain)

^b LRM   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INSULIN;

ADULT; APNEA; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MALE; MASCULINITY; METABOLIC DISORDER; METABOLIC SYNDROME X; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; SLEEP APNEA, OBSTRUCTIVE; STATISTICS; TREATMENT OUTCOME;

EID: 3242667810     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.01.025     Document Type: Article

References (27)

1. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease. Am J Respir Crit Care Med. 163:2001;19-25
2. Peppard P., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 342:2000;1378-1384
3. Young T., Peppard P. Sleep-disordered breathing and cardiovascular disease epidemiological evidence for a relationship. Sleep. 23:(suppl 4):2000;S122-S126
4. Fletcher E.C. Cardiovascular consequences of obstructive sleep apnea experimental hypoxia and sympathetic activity. Sleep. 23:(suppl):2000;S127-S131
5. Ridker P.M., Rifai N., Rose L., et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 347:2002;1557-1565
6. Koening W., Sund M., Frölich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 99:1999;237-242
7. Rifai N., Ridker P.M. High-sensitivity c-reactive protein a novel and promising marker of coronary heart disease. Clin Chem. 47:2001;403-411
8. Shamsuzzaman A.S.M., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 105:2002;2462-2464
9. Ip M.S.M., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 165:2002;670-676
10. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 165:2002;677-682
11. Visser M., Bouter L.M., McQuillan G.M., et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 282:1999;2131-2135
12. Kopelman P.G. Obesity as a medical problem. Nature. 404:2000;635-643
13. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 283:2000;1829-1836
14. Frölich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome a population-based study. Diabetes Care. 23:2000;1835-1839
15. Sullivan C.E., Berthon-Jones M., Issa F.G., Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1:1981;862-865
16. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. Bethesda, Maryland: National Institutes of Health; 1998
17. Johns M.W. A new method for measuring daytime sleepiness the Epworth sleepiness scale. Sleep. 14:1991;540-545
18. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostatic model assessment insulin resistance and B-cell function from fasting glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419
19. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 107:2003;1129-1134
20. Chin K., Nakamura T., Shimizu K., et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med. 109:2000;562-567
21. Wessendorf T.E., Thilmann A.F., Wang Y.M., Schreiber A. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med. 162:2000;2018-2020
22. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique. A method for quantifying insulin secretion and resistance. Am J Physiol. 237:1979;E214-E223
23. Bonora E., Targuer G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care. 23:2000;57-63
24. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease prospective study and updated meta-analysis. BMJ. 321:2000;199-204
25. Lindahl B., Toss H., Siegbahn A., et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 343:2000;1139-1147
26. Dicimetiere P., Eschwege E., Papoz L., et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 19:2003;205-210
27. Hargreaves A.D., Logan R.L., Elton R.A., et al. Glucose tolerance, plasma insulin, HDL cholesterol and obesity 12-year follow-up an development of coronary heart disease in Edinburgh men. Atherosclerosis. 94:1992;64-69